The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
Abstract
The aim of this study was to compare the effects of the genetic and pharmacological disruption of CB1 cannabinoid receptors on the elevated plus‐maze test of anxiety. In the first experiment, the behaviour of CB1‐knockout mice and wild‐type mice was compared. In the second experiment, the cannabinoid antagonist SR141716A (0, 1, and 3 mg/kg) was administered to both CB1‐knockout and wild type mice. Untreated CB1‐knockout mice showed a reduced exploration of the open arms of the plus‐maze apparatus, thus appearing more anxious than the wild‐type animals, however no changes in locomotion were noticed. The vehicle‐injected CB1‐knockout mice from the second experiment also showed increased anxiety as compared with wild types. Surprisingly, the cannabinoid antagonist SR141716A reduced anxiety in both wild type and CB1 knockout mice. Locomotor behaviour was only marginally affected. Recent evidence suggests the existence of a novel cannabinoid receptor in the brain. It has also been shown that SR141716A binds to both the CB1 and the putative novel receptor. The data presented here supports these findings, as the cannabinoid receptor antagonist affected anxiety in both wild type and CB1‐knockout mice. Tentatively, it may be suggested that the discrepancy between the effects of the genetic and pharmacological blockade of the CB1 receptor suggests that the novel receptor plays a role in anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which in turn give rise to an anxious/depressive phenotype20, 21.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [20]
Citations
Cites
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Self-citationA review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety
Hogg, S. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02126-4 · Cited by 1,169
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 597
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 538
Involvement of CB1 cannabinoid receptors in emotional behaviour
Martín, M., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 525
Self-citationHájos, N., Ledent, C. A., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 421
Self-citationMarzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 394
Compton, D. M., Aceto, M. D. G., Lowe, J. A., III, & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357
Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312
Cited by
Sorted by citations
Items 301–354 of 354
Endocannabinoids, Stress, and Negative Affect
Berger, A. L., Henricks, A. M., Hill, M. N., & McLaughlin, R. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_3 · Cited by 2
Wood, C. P., Avalos, B., Alvarez, C., & DiPatrizio, N. V. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0150 · Cited by 2
Gaudette, E. V., Watling, S. E., Warsh, J. J., McCluskey, T., Tong, J., Houle, S., Rusjan, P., Rhind, S. G., Bazinet, R. P., Tyndale, R. F., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.729 · Cited by 2
Behavioral Effects of Endocannabinoids
Fride, E., Thiébot, M.-H., Onaivi, E. S., & Chaperon, F. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.ch13 · Cited by 2
Peixoto, N., & Fonseca, R. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1745994 · Cited by 2
Role of the Endocannabinoid System in Anxiety and Stress-Related Disorders
Akirav, I. (2011) · InTech eBooks · doi:10.5772/18405 · Cited by 2
The role of endocannabinoid function in posttraumatic stress disorder
Gabbay, F. H., Choi, K. H., Wynn, G. H., & Ursano, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00011-4 · Cited by 1
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50044-8 · Cited by 1
Kim, H. J. J., Petrishen, D. A., Laprairie, R. B., & Peters, E. M. (2022) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2022.100095 · Cited by 1
A „bika drog” rendészeti neurobiológiája
Rompos, É., Baráth, N. E., Bellavics, M. Z., Lohner, K., & Haller, J. (2021) · Belügyi Szemle · doi:10.38146/bsz.2021.4.1 · Cited by 1
Self-citationO’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_5 · Cited by 1
Medicinal Cannabis for Alzheimer's Disease
Steiner, G. Z., Coles, M., Jaye, K. M., Metri, N., Butt, A. S., Christofides, K., McPartland, J., Al-Modhefer, Z., Karamacoska, D., Russo, E. B., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch001 · Cited by 1
Olango, W. M. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17506 · Cited by 1
Clinical decision making: a study to define educational objectives for resident physicians.
Hickam, D. H., & Cooney, T. G. (1986) · PubMed · Cited by 1
da Silva, J. A. (2011) · doi:10.11606/d.17.2011.tde-14082013-123119
Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system
Touriño, C. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Behavioral Profile of the Novel Cannabinoid Agonist AM4054
McClure, E. D. (2006) · OpenCommons - UConn (University of Connecticut)
Kannabinoid tip 1 reseptör (CB1) ve terapötik yaklaşımlara genel bakış-I
Çınar, R., & Gunduz‐Cinar, O. (2014) · DergiPark (Istanbul University)
Untersuchungen zur Rolle des endogenen Cannabinoidsystems bei der Anpassung an aversive Situationen
Kamprath, K. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6000
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.021
Role of the endocannabinoid system in human brain functions relevant for psychiatric disorders
Bossong, M. G. (2008) · Utrecht University Repository (Utrecht University)
CB1 Receptor Antagonist AM-251: Effect on Spatial Memory in Male Mice
Green, B. M. (2009) · California State University ScholarWorks (system-wide DSpace)
Role of the Cannabinoid Receptor Type 1 (CB1) in Synaptic Plasticity, Memory and Emotionality
Jacob, W. (2007) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.7230
Effect of Cannabinoid Receptor Agonist WIN55, 212-2 on the Anxiety Induced by PTSD in Male Rats
Ghasemi, M., Abrari, K., Goudarzi, I., Rashidy‐Pour, A., & Salmani, M. E. (2014)
Dunbar, M. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3115
Roles and Actions of Arachidonic Acid-Derived Bioactive Lipids in Stress-Related Behaviors
Furuyashiki, T., & Kitaoka, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55669-5_22
Sex Differences in the Anxiety Effects of Cannabinoids
French, H. T. (2017) · CUNY Academic Works (City University of New York)
Kupferschmidt, D. A. (2012) · TSpace (University of Toronto)
ENDOCANNABINOID REGULATION OF ADOLESCENT DEVELOPMENT IN MALE AND FEMALE RATS
Simone, J. J. (2018) · Brock University Digital Repository (Brock University)
Khan, A. U. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-29042019-162811
(2014) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/5.12.40-57
Envolvimento dos receptores CB1 nos efeitos comportamentais e pró-neurogênicos da venlafaxina
de Araujo, M. R. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-01062020-072523
(2020) · Society for Neuroscience eBooks · doi:10.1523/hon.011002
Jacotte-Simancas, A., Molina, P. E., & Gilpin, N. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.30.542943
Biomedical and public health studies on susceptibility to post-traumatic stress disorder
Jowf, G. I. A. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230906ga
Coelho, A. A. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-25072024-105142
Molecular mechanisms of cannabinergics
Maghembe, R. S., & Mtewa, A. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00012-8
Kroll, S. L., & Mayo, L. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00002-0
Mood, Motivation, and Mental Health
Dedam, J.-P. H., Fogel, M., & Fogel, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-87484-0_13
Endocannabinoids and the neurobiology of emotional states
Petrie, G. N., Lunge, A. R., Mayo, L. M., & Hill, M. N. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00021-9
Harloe, J. P. (2008) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/3826-5762
Boury‐Esnault, N., Marschal, C., Probst, J.-M. K., & Barnathan, G. (2002) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.155630
Role of the type-1 cannabinoid receptor in the control of water intake
Zhao, Z. (2019) · theses.fr (ABES) · doi:10.70675/ca103186z8d92z4d94zaf67zcce657f39cd1
Roles of astroglial cannabinoid type 1 receptors (CB1) in memory and synaptic plasticity
Robin, L. M. (2018) · theses.fr (ABES) · doi:10.70675/1fd1dda8z3f4bz404azbdf6z5b648e4c4053
Mohammadkhani, A., Peterson, C. S., & Borgland, S. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_14
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_5
BindingDB (2021) · UC San Diego · doi:10.7270/q20c508w
The role of the CB1 receptor in learning, memory and anxiety-like behaviors
Bolyard, L. L. (2009) · The Mathematics Enthusiast
Metadata
- Authors
- Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F.
- Affiliations
- HUN-REN Institute of Experimental Medicine (HU)
- Université Libre de Bruxelles (BE)
- Corresponding author
- Freund, T. F.
- ORCID
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2002-10
- Volume
- 16
- Issue
- 7
- Pages
- 1395-1398
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2027352187
- Cited by
- 354
- References
- 26
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 5 · 2023: 14 · 2022: 6 · 2021: 14 · 2020: 9 · 2019: 8 · 2018: 11 · 2017: 13 · 2016: 11 · 2015: 16 · 2014: 16 · 2013: 18 · 2012: 18
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Funders
- Hungarian Scientific Research Fund
- National Institute of Mental Health (R01MH054671, MH54671)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- CB1 receptor, anxiety, CB1 knockout mice, SR141716A, cannabinoid receptor antagonists, elevated plus maze, locomotor behaviour
- MeSH terms
- Rimonabant, Animals, Anxiety, Exploratory Behavior, Motor Activity, Piperidines, Pyrazoles, Receptors, Drug, Mice, Knockout, Maze Learning, Receptors, Cannabinoid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review